Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
- 4 December 2014
- journal article
- review article
- Published by Elsevier BV in Cytokine
- Vol. 74 (1), 27-34
- https://doi.org/10.1016/j.cyto.2014.10.031
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Inhibition of Fas Ligand in NOD Mice Unmasks a Protective Role for IL-10 against Insulitis DevelopmentThe American Journal of Pathology, 2011
- The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand populationHuman Immunology, 2011
- Structure and Mechanism of Receptor Sharing by the IL-10R2 Common ChainStructure, 2010
- Systemic but Not Local Infections Elicit Immunosuppressive IL-10 Production by Natural Killer CellsCell Host & Microbe, 2009
- Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodiesQJM: An International Journal of Medicine, 2009
- Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytesEuropean Journal of Immunology, 2008
- Dendritic cells and cytokines in human inflammatory and autoimmune diseasesCytokine & Growth Factor Reviews, 2008
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple SclerosisThe American Journal of Pathology, 2008
- Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery PhaseMediators of Inflammation, 2006